Detection of subclinical myocardial dysfunction in cocaine addicts with feature tracking cardiovascular magnetic resonance

Autor: Alicia M. Maceira, Sara Guardiola, Carmen Ripoll, Juan Cosin-Sales, Vicente Belloch, Jose Salazar

Publikováno v: Journal of Cardiovascular Magnetic Resonance, Vol 22, Iss 1, Pp 1-12 (2020)

Abstract Background Cocaine is an addictive, sympathomimetic drug with potentially lethal effects. We have previously shown with cardiovascular magnetic resonance (CMR) the presence of cardiovascular involvement in a significant percentage of consecu

Externí odkaz: https://doaj.org/article/76b022e2beeb4e078f8422dcf363071d

Predicting performance of the HAS-BLED and ORBIT bleeding risk scores in patients with atrial fibrillation treated with Rivaroxaban: Observations from the prospective EMIR Registry

Autor: María A Esteve-Pastor, José M Rivera-Caravaca, Vanessa Roldán, Marcelo Sanmartin Fernández, Fernando Arribas, Jaime Masjuan, Vivencio Barrios, Juan Cosin-Sales, Román Freixa-Pamias, Esther Recalde, Alejandro I Pérez-Cabeza, José Manuel Vázquez Rodríguez, Carles Ràfols Priu, Manuel Anguita Sánchez, Gregory Y H Lip, Francisco Marin

Publikováno v: Esteve-Pastor, M A, Rivera-Caravaca, J M, Roldán, V, Fernández, M S, Arribas, F, Masjuan, J, Barrios, V, Cosin-Sales, J, Freixa-Pamias, R, Recalde, E, Pérez-Cabeza, A I, Rodríguez, J M V, Priu, C R, Sánchez, M A, Lip, G Y H & Marin, F 2023, ' Predicting performance of the HAS-BLED and ORBIT bleeding risk scores in patients with atrial fibrillation treated with Rivaroxaban : Observations from the prospective EMIR Registry ', European heart journal. Cardiovascular pharmacotherapy, vol. 9, no. 1, pp. 38-46 . https://doi.org/10.1093/ehjcvp/pvac060

Background Assessing bleeding risk during the decision-making process of starting oral anticoagulation (OAC) therapy in atrial fibrillation (AF) patients is essential. Several bleeding risk scores have been proposed for vitamin K antagonist users but

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cbffcb0afd9e1a00c1add23c67a0313
https://doi.org/10.1093/ehjcvp/pvac060

Outcomes and predictive value of the 2MACE score in patients with atrial fibrillation treated with rivaroxaban in a prospective, multicenter observational study: The EMIR study

Autor: Marcelo Sanmartín Fernández, Manuel Anguita Sánchez, Fernando Arribas, Gonzalo Barón-Esquivias, Vivencio Barrios, Juan Cosin-Sales, María Asunción Esteve-Pastor, Roman Freixa-Pamias, Iñaki Lekuona, Alejandro I. Pérez-Cabeza, Isabel Ureña, José Manuel Vázquez Rodríguez, Carles Rafols Priu, Francisco Marin

Publikováno v: Cardiology Journal. 29:601-609

The aim of the study was to evaluate the performance of the 2MACE in patients with atrial fibrillation (AF) treated with rivaroxaban and to improve the accuracy of 2MACE.This was a post-authorization and observational study of AF adults treated with

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bab2e783b7194357d4a445e71d56f35
https://doi.org/10.5603/cj.a2022.0044

Identification of secondary prevention patients eligible for PCSK9 inhibitors therapy according to the routine clinical practice in Spain

Autor: Juan Cosin-Sales, Eduard Sidelnikov, Santiago Villamayor, Miriam Fernández, Sandra Merino-Montero, Alberto Zamora

Purpose Many patients at very-high risk of cardiovascular (CV) events would benefit from lipid lowering therapies (LLT) intensification to decrease their risk. This study aimed to identify the real-world secondary prevention patients potentially elig

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8ed928ae1fc3c46a2edd4425f8303e6
https://doi.org/10.21203/rs.3.rs-1909476/v1

Have the Government's prescription algorithm and the 2013 American College of Cardiology/American Heart Association guidelines for managing dyslipidemia influenced the management of dyslipidemia? The MEJORALO-CV Project

Autor: Enrique Rodilla Sala, Carlos Morillas Ariño, L. Fácila Rubio, Enrique Gómez Segado, Eduardo Rovira Daudí, José María Cepeda Rodrigo, Juan Cosin Sales, I. Bonig Trigueros, F. Valls Roca, C. Soler Portmann, V. Pallarés Carratalá, Rafael Durá Belinchón, P. Morillas Blasco, David Vicente Navarro, V. Pascual Fuster, Saray Monleón Arenós, V. Giner Galvañ, J.J. Tamarit García, S. Martínez Hervás

Publikováno v: Revista Clínica Española (English Edition). 220:282-289

Objective To determine the management of dyslipidemia in primary care after the publication of the American College of Cardiology/American Heart Association (ACC/AHA) 2013 guidelines and Valencian government's algorithm. Method We conducted a cross-s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::63ffb4797c955dd71aa00f351fabed0f
https://doi.org/10.1016/j.rceng.2019.08.006